OTCMKTS:TRSSF

TerrAscend - TRSSF Stock Forecast, Price & News

$2.17

-0.07 (-3.13%)

(As of 12/6/2022 12:00 AM ET)

Add

Compare

Today's Range: $1.77
▼
$2.38
50-Day Range: $1.28
▼
$2.24
52-Week Range: $1.21
▼
$6.55

Volume: 759,449 shs
Average Volume: 622,029 shs
Market Capitalization: $546.54 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.57

TerrAscend MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.63 Rating Score
Upside/Downside: 64.4% Upside
$3.57 Price Target
Short Interest: Healthy
0.23% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.14
Based on 24 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.13) to ($0.11) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.96 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
TerrAscend has received a consensus rating of Buy. The company's average rating score is 2.63, and is based on 5 buy ratings, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $3.57, TerrAscend has a forecasted upside of 64.4% from its current price of $2.17.
Amount of Analyst Coverage
TerrAscend has only been the subject of 2 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.23% of the outstanding shares of TerrAscend have been sold short.
Short Interest Ratio / Days to Cover
TerrAscend has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in TerrAscend has recently increased by 2.43%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
TerrAscend does not currently pay a dividend.
Dividend Growth
TerrAscend does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for TRSSF.

1.7

News and Social Media Coverage

News Sentiment
TerrAscend has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 24 news articles for TerrAscend this week, compared to 3 articles on an average week.
MarketBeat Follows
Only 1 people have added TerrAscend to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, TerrAscend insiders have not sold or bought any company stock.
Percentage Held by Insiders
44.32% of the stock of TerrAscend is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 0.04% of the stock of TerrAscend is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for TerrAscend are expected to grow in the coming year, from ($0.13) to ($0.11) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of TerrAscend is -1.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of TerrAscend is -1.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
TerrAscend has a P/B Ratio of 1.81. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About TerrAscend (OTCMKTS:TRSSF) Stock

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. In addition, it owns various synergistic under Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. brands. As of July 26, 2022, the company operated 27 dispensaries, including 3 Cookies dispensaries in Michigan and 1 in Toronto. TerrAscend Corp. was incorporated in 2017 and is headquartered in Mississauga, Canada.

Receive TRSSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TerrAscend and its competitors with MarketBeat's FREE daily newsletter.